Roy B. Lefkowitz

509 total citations
9 papers, 383 citations indexed

About

Roy B. Lefkowitz is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Roy B. Lefkowitz has authored 9 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Hematology and 3 papers in Cancer Research. Recurrent topics in Roy B. Lefkowitz's work include Blood Coagulation and Thrombosis Mechanisms (4 papers), Protease and Inhibitor Mechanisms (3 papers) and Advanced Biosensing Techniques and Applications (2 papers). Roy B. Lefkowitz is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (4 papers), Protease and Inhibitor Mechanisms (3 papers) and Advanced Biosensing Techniques and Applications (2 papers). Roy B. Lefkowitz collaborates with scholars based in United States. Roy B. Lefkowitz's co-authors include Geert W. Schmid‐Schönbein, Michael J. Heller, Daniel S. Grosu, Tong Liu, John A. Tynan, Eyad Almasri, Grant Hogg, Chen Zhao, Amin R. Mazloom and Graham McLennan and has published in prestigious journals such as Angewandte Chemie International Edition, Analytical Chemistry and American Journal of Obstetrics and Gynecology.

In The Last Decade

Roy B. Lefkowitz

8 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roy B. Lefkowitz United States 7 174 114 67 61 57 9 383
Christian A. Fernandez United States 16 318 1.8× 155 1.4× 89 1.3× 110 1.8× 61 1.1× 33 725
Patrizia Rubino Italy 14 199 1.1× 160 1.4× 43 0.6× 20 0.3× 51 0.9× 24 692
Adele S. Ricciardi United States 12 423 2.4× 40 0.4× 69 1.0× 25 0.4× 33 0.6× 22 570
Parvin Mahdipoor Canada 14 396 2.3× 26 0.2× 43 0.6× 53 0.9× 109 1.9× 22 601
Anil Kumar Tomar India 13 220 1.3× 12 0.1× 65 1.0× 69 1.1× 30 0.5× 44 646
Sang‐Hwan Hyun South Korea 14 307 1.8× 28 0.2× 150 2.2× 24 0.4× 13 0.2× 51 582
Marcela D Salazar United States 10 223 1.3× 9 0.1× 37 0.6× 72 1.2× 55 1.0× 13 558
Elena Fernández Fernández Ireland 12 405 2.3× 15 0.1× 62 0.9× 48 0.8× 25 0.4× 19 629
Nancy L. Boman Canada 9 399 2.3× 33 0.3× 12 0.2× 101 1.7× 12 0.2× 10 692

Countries citing papers authored by Roy B. Lefkowitz

Since Specialization
Citations

This map shows the geographic impact of Roy B. Lefkowitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy B. Lefkowitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy B. Lefkowitz more than expected).

Fields of papers citing papers by Roy B. Lefkowitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy B. Lefkowitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy B. Lefkowitz. The network helps show where Roy B. Lefkowitz may publish in the future.

Co-authorship network of co-authors of Roy B. Lefkowitz

This figure shows the co-authorship network connecting the top 25 collaborators of Roy B. Lefkowitz. A scholar is included among the top collaborators of Roy B. Lefkowitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy B. Lefkowitz. Roy B. Lefkowitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lefkowitz, Roy B., John A. Tynan, Tong Liu, et al.. (2016). Clinical validation of a noninvasive prenatal test for genomewide detection of fetal copy number variants. American Journal of Obstetrics and Gynecology. 215(2). 227.e1–227.e16. 134 indexed citations
2.
Lefkowitz, Roy B., et al.. (2016). Thrombin generation assay in untreated whole human blood. Electrophoresis. 37(15-16). 2248–2256. 3 indexed citations
3.
Whitney, Michael, Elamprakash N. Savariar, Beth Friedman, et al.. (2012). Ratiometric Activatable Cell‐Penetrating Peptides Provide Rapid In Vivo Readout of Thrombin Activation. Angewandte Chemie International Edition. 52(1). 325–330. 93 indexed citations
4.
Torres‐Gonzalez, Moises, et al.. (2012). Proof of Concept: Matrix metalloproteinase inhibitor decreases inflammation and improves muscle insulin sensitivity in people with type 2 diabetes. Journal of Inflammation. 9(1). 35–35. 28 indexed citations
5.
Whitney, Michael, Elamprakash N. Savariar, Beth Friedman, et al.. (2012). Ratiometric Activatable Cell‐Penetrating Peptides Provide Rapid In Vivo Readout of Thrombin Activation. Angewandte Chemie. 125(1). 343–348. 14 indexed citations
6.
Lefkowitz, Roy B., Geert W. Schmid‐Schönbein, & Michael J. Heller. (2010). Whole blood assay for trypsin activity using polyanionic focusing gel electrophoresis. Electrophoresis. 31(14). 2442–2451. 37 indexed citations
7.
Lefkowitz, Roy B., Geert W. Schmid‐Schönbein, & Michael J. Heller. (2010). Whole blood assay for trypsin activity using polyanionic focusing gel electrophoresis. PROTEOMICS - CLINICAL APPLICATIONS. 4(10-11). 874–874.
8.
Lefkowitz, Roy B., Geert W. Schmid‐Schönbein, & Michael J. Heller. (2010). Whole Blood Assay for Elastase, Chymotrypsin, Matrix Metalloproteinase-2, and Matrix Metalloproteinase-9 Activity. Analytical Chemistry. 82(19). 8251–8258. 32 indexed citations
9.
Lefkowitz, Roy B., Jennifer Y. Marciniak, Che‐Ming Jack Hu, Geert W. Schmid‐Schönbein, & Michael J. Heller. (2009). An electrophoretic method for the detection of chymotrypsin and trypsin activity directly in whole blood. Electrophoresis. 31(2). 403–410. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026